Internal Medicine, Endocrinology, Diabetes, & Metabolism · Birmingham, AL
NPI
1073807871
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3525 Independence Dr
Birmingham, AL, 35209
Phone (205) 971-2475
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
762 services
Medicare patients, 2024
223
Average age 72
Drug cost, 2024
$1.7M
3,494 prescriptions
Company payments, 2025
$2,193
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farah Y Ghori-Javed was code 99214 (office e&m - established), 259 times for 145 patients. In total Farah Y Ghori-Javed billed 762 services in 12 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 259 | 145 | $80.82 | $21K |
| 83036 Blood Count | Office | 133 | 89 | $9.36 | $1,246 |
| 82962 Clinical Chemistry | Office | 104 | 74 | $3.21 | $334 |
| 99213 Office E&M - Established | Office | 86 | 68 | $59.51 | $5,118 |
| 99204 Office E&M - New | Office | 69 | 69 | $99.13 | $6,840 |
| 95251 Test - Miscellaneous | Office | 56 | 32 | $24.77 | $1,387 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 29 | $11.82 | $343 |
| 99203 Office E&M - New | Office | 15 | 15 | $70.36 | $1,055 |
By year: 2022 $18K for 208 services; 2023 $45K for 594 services; 2024 $38K for 762 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 133 | 89 | $9.36 | $1,246 |
| 82962 Clinical Chemistry | 104 | 74 | $3.21 | $334 |
Medicare prescription drug claims, 2024
In 2024, the drug Farah Y Ghori-Javed prescribed most often to Medicare patients was Levothyroxine Sodium, with 555 prescriptions and refills. In total Farah Y Ghori-Javed wrote 3,494 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 555 | 1,159 | 150 | $5,622 |
| Mounjaro Tirzepatide | 320 | 344 | 54 | $362K |
| Ozempic Semaglutide | 193 | 226 | 38 | $208K |
| Farxiga Dapagliflozin Propanediol | 167 | 233 | 37 | $127K |
| Jardiance Empagliflozin | 109 | 153 | 26 | $84K |
| Metformin Hcl Generic | 99 | 212 | 32 | $542 |
| Synthroid Levothyroxine Sodium | 91 | 199 | 25 | $7,277 |
| Methimazole Generic | 88 | 109 | 20 | $553 |
| Hydrocortisone Generic | 81 | 92 | 15 | $2,796 |
| Tresiba Flextouch U-100 Insulin Degludec | 70 | 126 | 20 | $43K |
| Glipizide Generic | 65 | 124 | 20 | $660 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 64 | 111 | 21 | $5,884 |
| Humalog Kwikpen U-100 Insulin Lispro | 56 | 78 | 14 | $12K |
| Losartan Potassium Generic | 52 | 117 | 15 | $390 |
| Lyumjev Kwikpen U-100 Insulin Lispro-Aabc | 49 | 60 | Under 11 | $26K |
Brand drugs: 2,011 claims; generic drugs: 1,367 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farah Y Ghori-Javed $2,193 ($2,193 in general payments such as food, travel and fees) from 26 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $293.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $293 |
| Lilly USA, LLC LLY | 13 | $256 |
| Xeris Pharmaceuticals, Inc. | 14 | $252 |
| Corcept Therapeutics CORT | 6 | $147 |
| Abbott Laboratories ABT | 7 | $145 |
| Novo Nordisk Inc NVO | 5 | $119 |
| Dexcom, Inc. DXCM | 5 | $103 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $102 |
| Beta Bionics, Inc. BBNX | 3 | $73.5 |
| Sanofi-Aventis U.S. LLC SNY | 3 | $72.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.